Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs OUTFRONT Media Inc. Common Stock (OUT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs OUTFRONT Media Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while OUTFRONT Media Inc. Common Stock trades at $29.55 (market cap $5.33B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and OUTFRONT Media Inc. Common Stock pays a 4.06% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and OUTFRONT Media Inc. Common Stock for 0 Days on average.
| KYMR | OUT | |
|---|---|---|
Market Cap | $8.87B | $5.33B |
Volume | 779,107 | 1,197,618 |
Sector | Health | Real Estate |
52-Week High | $127.31 | $33.90 |
52-Week Low | $55.80 | $17.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $9.43B |
Dividend Yield | — | 4.06% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About OUTFRONT Media Inc. Common Stock
OUTFRONT Media Inc. is a US out-of-home media REIT that provides advertising space on billboard and transit displays across major markets in US and Canada.
Read more on OUT →
